GlassScriptPhysician profile
Gregg E Zimmerman
NPI 1790766228
$9,023.80
in general payments reported to CMS, 2019-2025
57 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $198 · 2021: $978 · 2022: $978 · 2023: $2,733 · 2024: $1,828 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,668 · Travel and Lodging: $321 · Education: $155 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,667.99 |
| Travel and Lodging | $321.24 |
| Education | $154.98 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,035.14 | 2023 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $797.03 | 2019-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $667.49 | 2019-2025 | |
| Astellas Pharma US INC | $532.79 | 2019-2023 | Myrbetriq, Veozah |
| Myriad Genetic Laboratories, INC. | $481.46 | 2021-2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $430.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $403.74 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Sumitomo Pharma America, INC. | $339.06 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $327.66 | 2021-2024 | Ams 700 |
| Abbvie INC. | $286.45 | 2023-2024 | Botox, Lupron Depot |
| Progenics Pharmaceuticals, INC. | $251.65 | 2023-2025 | Pylarify |
| Davol INC. | $238.22 | 2019-2022 | |
| Procept Biorobotics Corporation | $237.46 | 2019-2022 | |
| 180 Medical, INC. | $227.97 | 2019-2025 | |
| Urogen Pharma, INC. | $225.35 | 2023-2025 | Jelmyto |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $221.89 | 2022-2025 | Lynparza |
| Ferring Pharmaceuticals INC. | $184.58 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $131.26 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $130.66 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $130.02 | 2020-2025 | Provenge |
| Telix Pharmaceuticals | $123.25 | 2023-2025 | Illuccix |
| Axonics, INC. | $122.17 | 2023 | Axonics, Bulkamid |
| Endo USA, INC. | $102.95 | 2025 | Xiaflex, Aveed |
| Getinge USA Sales, LLC | $102.80 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $94.88 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $92.59 | 2022-2024 | Xiaflex, Aveed |
| Caris Mpi, INC. | $87.88 | 2025 | Mi Cancer Seek |
| Myovant Sciences INC. | $87.72 | 2022 | |
| Immunitybio, INC. | $87.71 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $73.68 | 2024-2025 | |
| Tolmar, INC. | $72.34 | 2023-2025 | Jatenzo, Eligard |
| Ambu INC. | $64.54 | 2020-2021 | |
| Seagen INC. | $54.99 | 2025 | |
| Olympus America INC. | $53.48 | 2022-2025 | Itind System |
| Agiliti Surgical, INC. | $52.30 | 2023 | Sonablate |
| Antares Pharma, INC. | $50.79 | 2022-2025 | Xyosted |
| Becton, Dickinson and Company | $47.61 | 2024 | Channel Drain |
| Ethicon US, LLC | $41.87 | 2019-2023 | Surgicel Nu-Knit |
| Allergan, INC. | $41.29 | 2019-2021 | |
| Medtronic, INC. | $27.24 | 2021-2022 | |
| Blue Earth Diagnostics | $24.99 | 2019 | |
| Foundation Medicine, INC. | $23.98 | 2023 | |
| Cycle Pharmaceuticals INC | $21.50 | 2024 | Tiopronin |
| Cook Medical LLC | $18.77 | 2024 | Cook |
| Laborie Medical Technologies Corp. | $16.55 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $15.72 | 2024 | Cvac Aspiration System |
| Coloplast Corp | $14.71 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.66 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.51 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $14.44 | 2019 | |
| Clarus Therapeutics INC. | $14.35 | 2021 | |
| Bluewind Medical | $13.69 | 2024 | Revi |
| Profound Medical Corp. | $13.62 | 2025 | Tulsa-Pro |
| Metuchen Pharmaceuticals | $12.49 | 2019 | |
| Genzyme Corporation | $12.38 | 2022 | |
| Dentsply Ih INC. | $11.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $3.87 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.